Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine for chest tube pain control in traumatic rib fracture
IRCT20120716010297N6Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bupivacaine in rib fracture (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Narcotic dosage, Pain score and 5 more. Started Mar 2020; status: completed.
02
Drugs
bupivacaine
03
Conditions
rib fracture
Beyond the preview
Go deeper on IRCT20120716010297N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120716010297N6.